Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.340
-0.060 (-1.36%)
At close: Dec 8, 2025, 4:00 PM EST
4.271
-0.069 (-1.59%)
Pre-market: Dec 9, 2025, 8:50 AM EST
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $387.77 million as of December 9, 2025. Its market cap has decreased by -46.04% in one year.
Market Cap
387.77M
Enterprise Value
285.19M
1-Year Change
-46.04%
Ranking
Category
Stock Price
$4.34
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has increased from $284.60M to $387.77M, an increase of 36.25%. That is a compound annual growth rate of 3.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 387.80M | -57.43% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |